Kylie McNerlin
Family Medicine · Huntingdon, PANPI 1811474406
Payments from drug & device makers
Across 163 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$527
- AbbVie$480
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$295
- Novo Nordisk$282
- AstraZeneca$179
- GSK$157
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,89898%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 34 | $527 |
| AbbVie | 23 | $480 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $295 |
| Novo Nordisk | 16 | $282 |
| AstraZeneca | 11 | $179 |
| GSK | 5 | $157 |
| Otsuka America Pharmaceutical, Inc. | 8 | $146 |
| Pfizer | 8 | $138 |
| Exact Sciences | 6 | $101 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $95 |
| Johnson & Johnson | 5 | $90 |
| Merck | 5 | $83 |
| Boehringer Ingelheim | 4 | $75 |
| Phathom Pharmaceuticals, Inc. | 6 | $66 |
| Astellas Pharma US Inc | 3 | $59 |
| Amarin Pharma, Inc. | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Indivior Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Amgen | 1 | $12 |
How this compares
$2,945 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 80 | $91,736 |
| OzempicSemaglutide | 70 | $90,438 |
| EliquisApixaban | 64 | $76,714 |
| TrulicityDulaglutide | 35 | $40,124 |
| MounjaroTirzepatide | 30 | $34,624 |
| XareltoRivaroxaban | 32 | $34,254 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $25,275 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $19,302 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $15,379 |
| MyrbetriqMirabegron | 13 | $9,260 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $3,336 |
| Atorvastatin Calcium | 245 | $3,066 |
| Gabapentin | 161 | $2,780 |
| Rosuvastatin Calcium | 178 | $2,734 |
| Losartan Potassium | 191 | $2,559 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $75 | $91,73680 claims |
| Novo NordiskOzempic | $282 | $90,43870 claims |
| PfizerEliquis | $138 | $76,71464 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $527 | $74,74965 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $157 | $34,68061 claims |
| Johnson & JohnsonXarelto | $90 | $34,25432 claims |
| AstraZenecaBreztri Aerosphere | $179 | $25,27540 claims |
| Astellas Pharma US IncMyrbetriq | $59 | $9,26013 claims |
| AbbVieSynthroid | $480 | $1,60348 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Huntingdon
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.